Valvular Heart Disease 2022
A case-based discussion program on state of the art management of valvular heart disease. The format will involve cardiologists, cardiac surgeons, cardiac anesthesiologists, advanced care providers, and fellows in training presenting and discussing up to 10 cases that span the range of valvular heart disease.
Howard Herrmann, MD, director of interventional cardiology at Penn Medicine, reviews the evolution of TAVR at Penn Medicine and at a national level, including data trends, clinical trials and procedural innovations, and current state.
Penn Aorta Center Co-director Joseph Bavaria, MD, discusses the aortic valve repair program at Penn Medicine. He reviews three major areas of the aortic valve insufficiency and aortic valve repair paradigm: aortic valve sparing procedures, ...
Penn Aorta Center Co-director Nimesh Desai, MD, PhD, outlines the role of the Ross procedure for young patients with aortic valve disease, including how the modern Ross procedure is different, the evolution of Penn’s program, and who is a candidate.
Penn Medicine cardiovascular imaging specialist Tiffany Chen, MD, discusses the role of imaging in tricuspid valve disease with a focus on pre-procedural imaging.
Paul Fiorilli, MD, reviews investigational options for tricuspid regurgitation, including the TRILUMINATE and CLASP II repair clinical trials and the TRISCEND II replacement clinical trial.
Pavan Atluri, MD, director of minimally invasive and robotic cardiac surgery at Penn Medicine, reviews advantages of minimally invasive techniques for mitral regurgitation. Dr. Atluri uses case footage to review the Penn approach to robotic ...
Gene Chang, MD, director of the cardiac catheterization lab at Penn Presbyterian Medical Center, reviews MR classification and pathologies, history and timeline of edge-to-edge repair, clinical trial data, and emerging therapeutic options.
Howard Herrmann, MD, director of interventional cardiology at Penn Medicine, reviews mitral valve replacement vs. repair, current replacement options, and new clinical trial devices.
Penn Medicine cardiovascular imaging specialist Frank Silvestry, MD, discusses the role of interventional echocardiography and three new imaging options: 3D TEE, fusion imaging, and 3D ICE.
Michael Ibrahim, MD, PhD, director of mitral and reconstructive valve surgery at Penn Presbyterian Medical Center, reviews mitral annular calcification, including definition, related complications, surgical options with case footage, and contemporary results.
BROADCASTMED